Overview
- 43 inspections across 42 sites are on record.
- 133 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-21.
At a glance
Inspections
43
Sites
42
Observations
133
Career since
Apr 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| PLZ Corp | 21 May 2026 | Human Drugs | On file |
| TriRx Segre | 23 Apr 2026 | Animal Drugs & Feeds | On file |
| AstraZeneca AB | 10 Apr 2026 | Human Drugs | On file |
| K.C. Pharmaceuticals, Inc | 13 Feb 2026 | Human Drugs | On file |
| Metrochem API Private Limited | 19 Dec 2025 | Human Drugs |
Sites inspected
PLZ CorpRiverside, United States1 insp.
TriRx SegreSegre-En-Anjou Bleu, France1 insp.
AstraZeneca ABSodertalje, Sweden1 insp.
K.C. Pharmaceuticals, IncPomona, United States1 insp.
Metrochem API Private LimitedThanam, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Pearl C Ozuruigbo3 shared
Mabany Lizardi3 shared
Lillian S Wu3 shared
Sandra A Boyd3 shared
Sara H Gabel3 shared
Khoa Nathan V Tran3 shared
Hung H Do3 shared
Youkeun Kim2 shared
Rachel C Stanton2 shared
Eileen A Liu2 shared
Full investigator report
Get the verbatim findings behind Rowena S Nguyen's 133 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site